Appetite-Related Brain Activity in Women With Anorexia Nervosa
The Study of Appetite-Related Brain Activity With Functional Magnetic Resonance Imaging in Women With Anorexia Nervosa
Přehled studie
Postavení
Podmínky
Detailní popis
Anorexia nervosa (AN) is a serious eating disorder that is characterized by an extreme loss of appetite. People with AN view themselves as overweight and cannot bring themselves to eat, even though most are dangerously thin. Functional magnetic resonance imaging (fMRI) is a technique that can be used to determine which parts of the brain are activated by physical stimuli. When a certain stimulus is introduced, blood flow to the corresponding area of the brain increases. This increase in blood flow is depicted on the fMRI scan. A person with AN may have different responses to food when evaluated prior to treatment versus after treatment. This study will use fMRI to compare appetite-related brain activity in women with AN before and after receiving treatment for the disorder.
Participants in this study will undergo two fMRI scans. Participants with AN will have one scan before entering the "weight gain phase" of treatment for AN and another scan upon completion of treatment. Healthy volunteers will undergo scans during a similar time frame. Participants will not be allowed to eat from midnight on the night before the scan until after the fMRI procedure, but they may drink water. During the scan, participants will be shown various objects and real foods; they will also be asked to touch the objects and food with their eyes closed. Each visit will last approximately 45 minutes. Ear protectors will be provided to reduce scanner noise.
Typ studie
Zápis (Aktuální)
Kontakty a umístění
Studijní místa
-
-
New York
-
New York, New York, Spojené státy, 10032
- New York State Psychiatric Institute
-
-
Kritéria účasti
Kritéria způsobilosti
Věk způsobilý ke studiu
Přijímá zdravé dobrovolníky
Pohlaví způsobilá ke studiu
Metoda odběru vzorků
Studijní populace
Popis
Inclusion Criteria:
For Participants with AN:
- DSM-IV diagnosis of AN (restricting or binge eating/purging subtype)
- Medically stable (not continuing to lose weight and vital signs stable)
For Healthy Participants:
- Currently weighs 80-120% of ideal weight
- no history of binge eating disorder or vomiting
- no current or past psychiatric illness
Exclusion Criteria:
For Participants with AN:
- Currently taking medication
- Current substance abuse or dependence disorder
- History of suicide attempt or other self-injurious behavior within 6 months prior to study entry
- Non-removable metal on or inside the body (e.g., metal pacemaker, surgical clips, metallic-ink tattoos)
For Healthy Participants:
- Current or past psychiatric illness
- History of binge eating or vomiting
- Any significant medical or neurologic illness
- Currently taking medication
- History of drug or alcohol abuse within 3 months prior to study entry
- Non-removable metal on or inside the body (e.g., metal pacemaker, surgical clips, metallic-ink tattoos)
Studijní plán
Jak je studie koncipována?
Detaily designu
Kohorty a intervence
Skupina / kohorta |
|---|
|
Subjects and Controls
Patients with DSM-IV Anorexia Nervosa
|
Spolupracovníci a vyšetřovatelé
Vyšetřovatelé
- Vrchní vyšetřovatel: Laurel Mayer, MD, New York State Psychiatric Institute
Termíny studijních záznamů
Hlavní termíny studia
Začátek studia
Primární dokončení (Aktuální)
Dokončení studie (Aktuální)
Termíny zápisu do studia
První předloženo
První předloženo, které splnilo kritéria kontroly kvality
První zveřejněno (Odhad)
Aktualizace studijních záznamů
Poslední zveřejněná aktualizace (Odhad)
Odeslaná poslední aktualizace, která splnila kritéria kontroly kvality
Naposledy ověřeno
Více informací
Termíny související s touto studií
Klíčová slova
Další relevantní podmínky MeSH
Další identifikační čísla studie
- #4850
Tyto informace byly beze změn načteny přímo z webu clinicaltrials.gov. Máte-li jakékoli požadavky na změnu, odstranění nebo aktualizaci podrobností studie, kontaktujte prosím register@clinicaltrials.gov. Jakmile bude změna implementována na clinicaltrials.gov, bude automaticky aktualizována i na našem webu .